KARUNA THERAPEUTICS INC's ticker is KRTX and the CUSIP is 48576A100. A total of 2 filers reported holding KARUNA THERAPEUTICS INC in Q1 2024. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2023 | $1,278,452 | +84.1% | 4,039 | -1.7% | 0.77% | +71.7% |
| Q3 2023 | $694,376 | -23.6% | 4,107 | -2.0% | 0.45% | -18.1% |
| Q2 2023 | $908,504 | +16.5% | 4,190 | -2.4% | 0.55% | +10.5% |
| Q1 2023 | $779,514 | -1.0% | 4,292 | +7.1% | 0.50% | -9.7% |
| Q4 2022 | $787,244 | -33.3% | 4,006 | -23.7% | 0.55% | -35.3% |
| Q3 2022 | $1,181,000 | +62.4% | 5,251 | -8.6% | 0.85% | +64.5% |
| Q2 2022 | $727,000 | -6.9% | 5,747 | -6.7% | 0.52% | +4.7% |
| Q1 2022 | $781,000 | -6.8% | 6,163 | -3.7% | 0.49% | -0.6% |
| Q4 2021 | $838,000 | +0.8% | 6,400 | -5.8% | 0.50% | -7.8% |
| Q3 2021 | $831,000 | +13.5% | 6,791 | +5.7% | 0.54% | +8.2% |
| Q2 2021 | $732,000 | +262.4% | 6,426 | +282.0% | 0.50% | +233.6% |
| Q1 2021 | $202,000 | – | 1,682 | – | 0.15% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Pivotal bioVenture Partners Investment Advisor LLC | 782,008 | $142,043,933 | 58.49% |
| Nan Fung Group Holdings Ltd | 225,688 | $40,993,968 | 27.90% |
| Sofinnova Investments, Inc. | 1,773,124 | $322,070,243 | 20.60% |
| Artia Global Partners LP | 88,831 | $16,135,263 | 5.96% |
| DAFNA Capital Management LLC | 78,573 | $14,272,000 | 4.28% |
| First Light Asset Management, LLC | 243,675 | $44,261,127 | 3.98% |
| Nationale-Nederlanden Powszechne Towarzystwo Emerytalne S.A. | 47,376 | $8,605,377 | 3.04% |
| CATALYST PRIVATE WEALTH, LLC | 21,837 | $3,966,473 | 2.74% |
| Sands Capital Ventures, LLC | 58,895 | $10,697,688 | 2.64% |
| ARCH Venture Management, LLC | 30,000 | $5,449,200 | 2.63% |